Changes in Renal Perfusion During Hemodialysis in Patients with End-stage Renal Disease

Study acronym: HD-RPC
StatusUnknown
PhaseNot specified
Started

Record status This record was last updated September 19, 2024 (before its estimated September 3, 2026 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Residual renal function (RRF) characteristically declines after patients with end-stage renal disease (ESRD) initiate dialysis. Although RRF preservation correlates with improved patient\'s quality of life and survival prospects, poor understanding of the pathophysiology underlying RRF decline limits protection strategies.
Trial Details
NCT Number NCT06587997
Lead Sponsor Yuanjun Yang
Conditions
(from sponsor)		 End-stage Renal Disease
Related terms Kidney Failure, Chronic
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov